Atlas Trials

Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study

Clinical trial NCT01632904 · COMPLETED

Trial details

NCT number
NCT01632904
Sponsor
Incyte Corporation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Polycythemia Vera
Start date
2012-06-01
Primary completion
2014-03-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.